Catherine T.  Doherty net worth and biography

Catherine Doherty Biography and Net Worth

Catherine T. Doherty is Senior Vice President, Group Executive – Clinical Franchise Solutions & Marketing for Quest Diagnostics. She is responsible for overseeing the development of service offerings and growing the business in the areas of cardiovascular, metabolic & endocrinology, infectious disease & immunology, prescription drug monitoring & toxicology, general health and wellness, and sports diagnostics. Ms. Doherty is also responsible for QuestDirect, our consumer-initiated testing business, and Quest’s Employer & Insurer Solutions business, as well as Marketing.

Ms. Doherty joined Quest Diagnostics in 1990 and most recently was Senior Vice President, Physician Services Business. Prior to that, she served as Vice President, Hospital Services, and as Vice President, Office of the Chairman.

A certified public accountant, Ms. Doherty graduated from Montclair State University and holds a bachelor’s degree in business administration with a concentration in accounting.

What is Catherine T. Doherty's net worth?

The estimated net worth of Catherine T. Doherty is at least $9.52 million as of February 28th, 2024. Ms. Doherty owns 69,599 shares of Quest Diagnostics stock worth more than $9,516,967 as of April 24th. This net worth estimate does not reflect any other investments that Ms. Doherty may own. Additionally, Ms. Doherty receives a salary of $1,000,000.00 as SVP at Quest Diagnostics. Learn More about Catherine T. Doherty's net worth.

How old is Catherine T. Doherty?

Ms. Doherty is currently 61 years old. There are 4 older executives and no younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics is Mr. Michael E. Prevoznik, Senior VP & General Counsel, who is 62 years old. Learn More on Catherine T. Doherty's age.

What is Catherine T. Doherty's salary?

As the SVP of Quest Diagnostics Incorporated, Ms. Doherty earns $1,000,000.00 per year. There are 2 executives that earn more than Ms. Doherty. The highest earning executive at Quest Diagnostics is Mr. James E. Davis, Chairman, CEO & President, who commands a salary of $2,880,000.00 per year. Learn More on Catherine T. Doherty's salary.

How do I contact Catherine T. Doherty?

The corporate mailing address for Ms. Doherty and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Catherine T. Doherty's contact information.

Has Catherine T. Doherty been buying or selling shares of Quest Diagnostics?

Catherine T. Doherty has not been actively trading shares of Quest Diagnostics during the past quarter. Most recently, Catherine T. Doherty sold 5,557 shares of the business's stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $126.57, for a transaction totalling $703,349.49. Following the completion of the sale, the executive vice president now directly owns 69,599 shares of the company's stock, valued at $8,809,145.43. Learn More on Catherine T. Doherty's trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes Michael Deppe (CAO), Catherine Doherty (SVP), Mark Guinan (CFO), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 5 times. They sold a total of 15,150 shares worth more than $1,913,201.65. The most recent insider tranaction occured on February, 29th when SVP Michael E Prevoznik sold 5,611 shares worth more than $706,312.68. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 2/29/2024.

Catherine T. Doherty Insider Trading History at Quest Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2024Sell5,557$126.57$703,349.4969,599View SEC Filing Icon  
2/22/2024Sell821$126.14$103,560.9470,800View SEC Filing Icon  
11/28/2022Sell40,765$149.18$6,081,322.7067,733View SEC Filing Icon  
2/24/2022Sell2,750$126.26$347,215.00View SEC Filing Icon  
11/29/2021Sell37,565$156.81$5,890,567.65View SEC Filing Icon  
5/7/2021Sell8,536$139.96$1,194,698.5668,729View SEC Filing Icon  
9/2/2020Sell58,392$110.60$6,458,155.20126,803View SEC Filing Icon  
2/25/2020Sell405$112.73$45,655.6571,106View SEC Filing Icon  
4/4/2019Sell66,382$90.59$6,013,545.38133,908View SEC Filing Icon  
3/5/2018Sell5,556$101.00$561,156.0078,890View SEC Filing Icon  
2/28/2018Sell1,820$104.38$189,971.60View SEC Filing Icon  
2/26/2018Sell397$102.74$40,787.7871,926View SEC Filing Icon  
1/24/2018Sell21,294$104.00$2,214,576.0090,709View SEC Filing Icon  
6/19/2017Sell59,762$107.55$6,427,403.1078,582View SEC Filing Icon  
3/3/2017Sell7,162$98.28$703,881.3687,809View SEC Filing Icon  
1/30/2017Sell80,000$90.58$7,246,400.00119,321View SEC Filing Icon  
5/27/2016Sell47,334$77.27$3,657,498.18100,402View SEC Filing Icon  
4/25/2016Sell29,550$74.45$2,199,997.50106,285View SEC Filing Icon  
8/8/2014Sell25,000$60.12$1,503,000.00View SEC Filing Icon  
See Full Table

Catherine T. Doherty Buying and Selling Activity at Quest Diagnostics

This chart shows Catherine T Doherty's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More

Today's Range

Now: $135.47
Low: $134.95
High: $136.00

50 Day Range

MA: $128.50
Low: $123.80
High: $136.74

2 Week Range

Now: $135.47
Low: $119.59
High: $148.62

Volume

82,886 shs

Average Volume

1,045,786 shs

Market Capitalization

$15.05 billion

P/E Ratio

18.09

Dividend Yield

2.18%

Beta

0.91